Navigation Links
Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy
Date:8/14/2014

patient Phase 2 study in cystic fibrosis (CF) subjects with chronic Pa lung infection. KaloBios has received Orphan Drug designation from both the U.S. FDA and the European Medicines Agency for KB001-A for the treatment of Pa lung infection in CF patients. KB001-A has also received Fast Track Status from the U.S. FDA for the prevention of ventilator associated pneumonia. KaloBios is planning to seek a partner to help accelerate the development of this program.
  • KB004 is an anti-EphA3 mAb with potential in treating hematologic malignancies and solid tumors. KaloBios is running an ongoing Phase 1/2 study evaluating KB004 in hematologic malignancies. The Phase 1 dose escalation portion of that study in subjects with hematologic malignancies is fully enrolled with dosing ongoing. KaloBios initiated the Phase 2 expansion portion of the study focused on patients with certain EphA3 positive hematologic malignancies in 2014.
  • KB003 is an anti-GM-CSF mAb with potential to treat inflammatory diseases that was being developed for the treatment of severe asthma. In early 2014, KaloBios completed a Phase 2 clinical study in 160 patients with severe asthma which did not meet its primary endpoint of improvement in FEV1 from baseline as compared to placebo. As a result, KaloBios discontinued development of this compound in severe asthma, and is continuing to analyze the Phase 2 data to review with thought leaders. KaloBios is currently evaluating other possible indications in order to determine next steps, if any, in the development of KB003.
  • All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target and are designed for chronic therapeutic use. The company believes that antibodies produced using its Humaneered®
    '/>"/>

    SOURCE KaloBios Pharmaceuticals, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
    2. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
    3. Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
    4. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
    5. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
    6. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
    7. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
    8. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
    9. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
    10. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
    11. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
    (Date:2/26/2015)... , Feb. 26, 2015 Legislation passed ... a pharmacy provision to help prevent inappropriate prescriptions in ... Protecting the Integrity of Medicare Act (PIMA) of ... Chairman Kevin Brady (R-TX) and Ranking Member ... prescription drug abuse epidemic and implement the right policies, ...
    (Date:2/26/2015)... and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) has announced ... Global Strategic Business Report" report to their offering. ... for Radiation Therapy Equipment in US$ Million by the ... Radiation Therapy Simulator. The report provides separate comprehensive analytics ... Japan , Europe , ...
    Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
    ... committed to improving the health of its patients, workforce ... medical equipment to more eco-friendly alternatives that are free ... plastics that have been shown to harm human and ... purchase IV solution bags that are 100 percent PVC ...
    ... SHENZHEN, China, Jan. 19, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical ... developer, manufacturer and marketer of medical devices worldwide, today ... 2012 to be held between January 23 and 26 ... Health is the most important annual medical exhibition in ...
    Cached Medicine Technology:Kaiser Permanente Moves to Green Medical Supplies by Converting to Eco-Friendly IV Equipment 2Kaiser Permanente Moves to Green Medical Supplies by Converting to Eco-Friendly IV Equipment 3Mindray Medical to Exhibit at Arab Health 2012 in Dubai from January 23-26 2
    (Date:2/27/2015)... CA (PRWEB) February 27, 2015 ... Devices (IPD), has introduced miniature, wire bondable, silicon ESD ... Power LED markets. The ESD88NP and ... currents away from sensitive LED and IC products. ... Multilayer Varistors (MLV). All devices meet the requirements ...
    (Date:2/27/2015)... (PRWEB) February 27, 2015 Just a ... air for those suffering from Sjögren’s Syndrome after a ... by researchers at the University of Buffalo and Immco ... of research was to develop a new diagnostic ... the presence of new autoantibodies. Researchers aimed to develop ...
    (Date:2/27/2015)... 27, 2015 Today, February 27th, is "Shine ... , along with LXR Organics and Living ... Campaign to raise awareness and promote prevention, rescue and restoration ... by the END IT Coalition, slavery is the 2nd largest ... exists in 167 countries around the world. Slavery includes bonded ...
    (Date:2/27/2015)... February 27, 2015 Clinovo, a leading ... validated Electronic Data Capture (EDC) at the CALBIO2015 ... March 2nd and March 3rd at Booth # 141. ... and DIY CRF and edit-check builder allowing Clinical Trials ... matter of days, without any programming experience. Clinovo’s new ...
    (Date:2/27/2015)... Laguna Hills, CA (PRWEB) February 27, 2015 ... has been chosen as their Sage ERP Document Management ... ERP, Sage 300 ERP, Sage CRM and other complimentary ... ADSS Global have worked side-by-side for many years to ... their Sage ERP applications. , “We are thrilled ...
    Breaking Medicine News(10 mins):Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2
    ... published in the March issue of the Journal ... lung transplantation should be used with caution in patients ... associated with high rates of mortality after one year ... been the gold-standard treatment for a variety of end-stage ...
    ... Help Peripheral Arterial Disease (PAD) Patients With Critical ... Attempts to treat critical limb ischemia in ... are still thwarted by restenosis (the re-narrowing of ... stenting), the need for repeat treatments and the ...
    ... Inc., a provider of nanoproteomic analysis systems to life ... protein analysis system to The University of Manchester,s Stem ... Whetton. Professor Whetton is a pioneer in the use ... normal and leukaemic stem cells. The Cell Biosciences system ...
    ... enhance patient satisfaction, however, study finds , , TUESDAY, March ... system could help ease the increasing workload faced by ... such a system in the Kaiser Permanente health plan. ... patients to communicate via secure e-mails instead of a ...
    ... Detroit Piston player Rodney Stuckey is,rallying Detroit ... of a new,national campaign called Get Fit By Finals. The ... milk?" Body By Milk(R) Campaign and NBA FIT, the,NBA,s comprehensive ... and adults through fitness and nutrition. , ...
    ... 10 Swissray International, Inc. announced that they have ... Veterans Affairs to sell their complete line of digital ... Department of Defense, VA Medical Centers or Government Agencies ... the contract could be effective until December, 2016.Swissray has ...
    Cached Medicine News:Health News:Journal of American College of Surgeons finds lung transplantation should be used in older patients 2Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 2Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 3Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 4Health News:Cell Biosciences Announces First UK System Sale 2Health News:Electronic Communication May Be Boon to Doctors' Time 2Health News:got milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Remus Robinson Middle School 2Health News:got milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Remus Robinson Middle School 3Health News:got milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Remus Robinson Middle School 4Health News:got milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Remus Robinson Middle School 5Health News:Swissray Awarded US Government Contract 2
    Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
    Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
    IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
    ... Scrub swabsticks is formulated with ... to prevent dryness. It contains ... to 0.75% available iodine. Povidone-Iodine ... surface pathogens, including gram-negative and ...
    Medicine Products: